Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
暂无分享,去创建一个
S. Pastorino | S. Kesari | Pengfei Jiang | S. Pingle | M. Makale | N. Nomura | J. Crawford | D. Piccioni | Tiffany M Juarez | Marco Gymnopoulos | Gage Lambert | Natsuko Nomura
[1] N. Bander,et al. Prostate‐specific membrane antigen expression in tumor‐associated vasculature of breast cancers , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[2] S. Toms,et al. Molecular Biology of Brain Metastasis , 2014, International journal of molecular sciences.
[3] N. Keating,et al. Expected years of life lost for six potentially preventable cancers in the United States. , 2013, Preventive medicine.
[4] Helle K. Iversen,et al. Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy , 2012, Radiology and oncology.
[5] J. Bourgeois,et al. Cell‐penetrating anti‐GFAP VHH and corresponding fluorescent fusion protein VHH‐GFP spontaneously cross the blood‐brain barrier and specifically recognize astrocytes: application to brain imaging , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] K. Claffey,et al. Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization , 2012, PloS one.
[7] Darren Hargrave,et al. Paediatric and adult malignant glioma: close relatives or distant cousins? , 2012, Nature Reviews Clinical Oncology.
[8] D. Schiff,et al. Angiogenic inhibition in high-grade gliomas: past, present and future , 2012, Expert review of neurotherapeutics.
[9] Xuan Zhang,et al. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells. , 2012, International journal of oncology.
[10] R. Shao,et al. Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation* , 2012, The Journal of Biological Chemistry.
[11] Robert Langer,et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.
[12] Alexander R A Anderson,et al. Quantifying the Role of Angiogenesis in Malignant Progression of Gliomas: in Silico Modeling Integrates Imaging and Histology Nih Public Access Author Manuscript Introduction , 2011 .
[13] P. Gutin,et al. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. , 2011, Archives of pathology & laboratory medicine.
[14] Kornelia Polyak,et al. Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.
[15] S. Pastorino,et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells , 2011, Proceedings of the National Academy of Sciences.
[16] L. Ricci-Vitiani,et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.
[17] Rong Wang,et al. Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.
[18] P. Steeg,et al. Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.
[19] Y. Nakasu,et al. [Multidisciplinary management of brain metastases]. , 2010, Gan to kagaku ryoho. Cancer & chemotherapy.
[20] Ximing J. Yang,et al. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. , 2009, Human pathology.
[21] P. Brastianos,et al. VEGF inhibitors in brain tumors. , 2009, Clinical advances in hematology & oncology : H&O.
[22] Ho-Yyoung Lee,et al. Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors , 2009, The FEBS journal.
[23] N. Sibson,et al. The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.
[24] P. Low,et al. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. , 2009, Molecular pharmaceutics.
[25] Masahiro Inoue,et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.
[26] Eun Seong Lee,et al. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. , 2008, Small.
[27] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[28] A. Ieva,et al. Antiangiogenic Strategies in Medulloblastoma: Reality or Mystery , 2008, Pediatric Research.
[29] P. Pandolfi,et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.
[30] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[31] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[32] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[33] L. Crinò,et al. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. , 2007, The oncologist.
[34] N. Patil,et al. Brain metastases from breast cancer: management approach. , 2007, Journal of cancer research and therapeutics.
[35] G. Sauter,et al. Prostate‐specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique , 2007, Histopathology.
[36] A. Vicha,et al. Expression of glutamate carboxypeptidase II in human brain , 2007, Neuroscience.
[37] S. Vallabhajosula,et al. Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[39] Philippe Lambin,et al. A pathology-based substrate for target definition in radiosurgery of brain metastases. , 2006, International journal of radiation oncology, biology, physics.
[40] Dianqing Wu,et al. Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal Transduction , 2006, Molecular and Cellular Biology.
[41] R. Kole,et al. Analysis of prostate-specific membrane antigen splice variants in LNCap cells. , 2006, Oligonucleotides.
[42] J. Posner,et al. Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.
[43] Pieter Wesseling,et al. Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option , 2004, Clinical Cancer Research.
[44] R. Santucci,et al. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. , 2002, Cancer research.
[45] A. Ruifrok,et al. Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.
[46] V. Reuter,et al. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. , 1999, Cancer research.
[47] J. Nakayama,et al. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. , 1997, Cancer research.
[48] C. Cordon-Cardo,et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[49] P. Schellhammer,et al. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. , 1995, Urologic oncology.
[50] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.